Sentence examples for further considerations with from inspiring English sources

In a broader sense, the fascinating colors that appear in fall leaves and in ripening fruit, due to the degradation of chlorophyll, stimulate further considerations with respect to the biological[ 49] and ecological[ 50, 51] relevance of such color changes.

A further consideration with policy and funding implications is that experienced practitioners give credibility to programmes in communities.

It only retains and uses pairs of regions with high similarity for further consideration with regions of the third sequence and so on.

Since the hypothetical genes can provided no information regarding their putative function they were eliminated from further consideration with regards to their role in the disease process.

Dominance is a straightforward concept; if an intervention is less effective and more costly than at least one of its comparators, it is not included for further consideration with regard to the estimation of cost-effectiveness.

Dominance is a straightforward concept; if an intervention is less effective and more costly than at least one of its comparators, it is not for further consideration with regard to the estimation of cost-effectiveness.

This proves the utility of the direct QSAR principle in assessing a statistical model that could be supplemented with further considerations, as with residual QSAR and other validity measures, to provide the best understanding of the analyzed phenomenon.

In addition, the evolution of new adaptive equipment, including eye gaze technology, exoskeletons and bionics, will require further considerations for questions with and without devices or supports.

Thus instead of requiring the somewhat arbitrary selection of the top N molecules from a list ranked by docking score, the pharmacophore filtering method produces the clear result that 224 compounds are worthy of further consideration, either with experimental screening or with more detailed modeling work.

The inclusion or exclusion of such indirect costs in patients with haematological malignancies needs further consideration together with the quality of life benefits, as recommended by the 1998 Office of Health Economics report on NHL.

Geneva: World Health Organization; 1997, http://www.who.int/vaccine_research/feuill_1_4-2.pdf], with further considerations in two later documents [Moorthy VS, Reed Z, Smith PG.